Skip to content

Monitoring study on the effects of ingestion of a preparation containing a mixture of three plant extracts on male menopause and sexual function.

Monitoring study on the effects of ingestion of a preparation containing a mixture of three plant extracts on male menopause and sexual function. - Study to evaluate the effects of a plant extract mixture on male menopause and sexual function.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000054558
Enrollment
28
Registered
2024-06-04
Start date
2024-06-04
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult males

Interventions

One capsule containing 200 mg of the plant extracts mixture is taken daily for 8 weeks, followed by a 4-week post-observation period. Three capsules containing 200 mg of the plant extracts mixture are

Sponsors

JAPAN PHARMA Co., Ltd.
Lead Sponsor
Morishita Jintan Co., Ltd.
Collaborator

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1)Male employees aged between 20 and 80 years at the time of obtaining consent to participate in the trial. 2)Healthy participants who are not currently receiving treatment or medication. 3)Participants who are able to collect a specimen on the specified date and submit it by the specified method. 4)Participants who fully understand the purpose and content of the study and are able to give written consent.

Exclusion criteria

Exclusion criteria: 1)Participants who are currently under medical treatment by a physician for any disease. 2)Participants who regularly use health foods containing blackcurrant extract, red perilla extract, or inositol. 3)Participants who regularly use health foods (e.g. maca, krachaidum, fenugreek) or medicines (e.g. testosterone, ED drugs, AGA drugs) related to the male menopause or sexual function. 4)Participants who may have allergic reactions to the test food. 5)Participants with a history or current history of heart failure, renal failure, hepatitis or other diseases. 6)Participants who consume excessive alcohol. 7)Participants who are enrolled in other clinical trials. 8)Participants who plan to change their lifestyle drastically during the study period.

Design outcomes

Primary

MeasureTime frame
Free testosterone in saliva (before, 4 weeks after, and 8weeks after intake)

Secondary

MeasureTime frame
Aging males' symptoms (AMS score) Erection Hardness Score (EHS) Questionnaire on effectiveness

Countries

Japan

Contacts

Public ContactYosuke Inagaki

JAPAN PHARMA Co., Ltd. Osaka Lab.

inagaki@japan-pharma.jp090-4995-9966

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026